# Phase 3 Study of SNF472 for Calciphylaxis

> **NCT04195906** · PHASE3 · COMPLETED · sponsor: **Sanifit Therapeutics S. A.** · enrollment: 71 (actual)

## Conditions studied

- Calciphylaxis
- Calcific Uremic Arteriolopathy

## Interventions

- **DRUG:** Experimental: SNF472
- **DRUG:** Placebo Comparator: Placebo
- **DRUG:** Experimatenl SNF472 (Open-label)

## Key facts

- **NCT ID:** NCT04195906
- **Lead sponsor:** Sanifit Therapeutics S. A.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-12
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04195906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04195906, "Phase 3 Study of SNF472 for Calciphylaxis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04195906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*